Analytical Evaluation
IVRT and IVPT in Microneedle Product Evaluation
What IVRT and IVPT each measure, how their methods differ and how to use them in microneedle development.
What does IVRT measure?
In-vitro release testing is used to compare release behavior from a formulation or microneedle structure. Medium, apparatus, sampling and analytical conditions must be chosen so the method can distinguish relevant formulation or process changes.
What does IVPT add?
In-vitro permeation testing uses skin and a diffusion system to assess the process of active entering or passing through skin. Skin source and integrity, application conditions, sampling and mass balance can materially affect the output.
When should each method be used?
IVRT is often useful for formulation and process comparisons; IVPT can address a skin-interface question. A product may need one, both or a different model depending on its mechanism and development objective.
What makes a method useful?
A useful method has a defined question, appropriate controls and evidence that it is sufficiently discriminating for its intended use. Regulatory requirements and validation expectations must be considered separately when applicable.
Development comparison
| Method | Primary question |
|---|---|
| IVRT | How does an active release from the dosage form or structure? |
| IVPT | How does an active enter or pass through skin under the tested conditions? |
| Mass balance | Is recovered material accounted for across the selected compartments? |
Frequently asked questions
Can IVRT replace IVPT?
No. The methods examine different mechanisms and may both be needed depending on the product.
Why does skin source matter in IVPT?
Skin source and integrity can influence permeation behavior and need to be controlled and documented.
Are these tests registration endpoints by default?
Their role depends on product type, development stage and applicable regulatory expectations.
Related content
References
- USP General Chapter <1724> Semisolid Drug Products—Performance Tests.
- FDA guidance on in-vitro release and permeation testing, where applicable.
Published by CASMN — Beijing CAS Microneedle Technology Co., Ltd.